302 related articles for article (PubMed ID: 34123821)
1. Safety and Efficacy of Personalized Cancer Vaccines in Combination With Immune Checkpoint Inhibitors in Cancer Treatment.
Liao JY; Zhang S
Front Oncol; 2021; 11():663264. PubMed ID: 34123821
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment.
Zhao J; Chen Y; Ding ZY; Liu JY
Front Pharmacol; 2019; 10():1184. PubMed ID: 31680963
[TBL] [Abstract][Full Text] [Related]
3. [Cancer Vaccine Focused on Neoantigens].
Shindo Y; Hazama S; Nagano H
Gan To Kagaku Ryoho; 2019 Sep; 46(9):1367-1371. PubMed ID: 31530772
[TBL] [Abstract][Full Text] [Related]
4. Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient.
Gao S; Wang J; Zhu Z; Fang J; Zhao Y; Liu Z; Qin H; Wei Y; Xu H; Dan X; Yang L; Xu Q
Immunotherapy; 2023 Feb; 15(2):57-69. PubMed ID: 36651232
[TBL] [Abstract][Full Text] [Related]
5. Targeting neoantigens for cancer immunotherapy.
Zhao X; Pan X; Wang Y; Zhang Y
Biomark Res; 2021 Jul; 9(1):61. PubMed ID: 34321091
[TBL] [Abstract][Full Text] [Related]
6. Clinical Combinatorial Treatments Based on Cancer Vaccines: Combination with Checkpoint Inhibitors and Beyond.
Soltani M; Savvateeva LV; Ganjalikhani-Hakemi M; Zamyatnin AA
Curr Drug Targets; 2022; 23(11):1072-1084. PubMed ID: 35593358
[TBL] [Abstract][Full Text] [Related]
7. Sensitizing the Efficiency of ICIs by Neoantigen mRNA Vaccines for HCC Treatment.
Han R; Wang Y; Lu L
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258070
[TBL] [Abstract][Full Text] [Related]
8. The Role of Neoantigens in Cancer Immunotherapy.
Zhu Y; Liu J
Front Oncol; 2021; 11():682325. PubMed ID: 34513673
[TBL] [Abstract][Full Text] [Related]
9. Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications.
Tang L; Zhang R; Zhang X; Yang L
Front Oncol; 2021; 11():701777. PubMed ID: 34381724
[TBL] [Abstract][Full Text] [Related]
10. Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model.
Peterson M; Murphy SN; Lainson J; Zhang J; Shen L; Diehnelt CW; Johnston SA
BMC Immunol; 2020 May; 21(1):25. PubMed ID: 32370785
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant personalized cancer vaccines: the final frontier?
Richard G; Ruggiero N; Steinberg GD; Martin WD; De Groot AS
Expert Rev Vaccines; 2024; 23(1):205-212. PubMed ID: 38189107
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines.
Sanchez K; Page D; McArthur HL
Curr Probl Cancer; 2016; 40(2-4):151-162. PubMed ID: 27855963
[TBL] [Abstract][Full Text] [Related]
13. Tumor neoantigens: from basic research to clinical applications.
Jiang T; Shi T; Zhang H; Hu J; Song Y; Wei J; Ren S; Zhou C
J Hematol Oncol; 2019 Sep; 12(1):93. PubMed ID: 31492199
[TBL] [Abstract][Full Text] [Related]
14. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
Aldous AR; Dong JZ
Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
[TBL] [Abstract][Full Text] [Related]
15. Progress in Vaccine Therapies for Breast Cancer.
Li X; Bu X
Adv Exp Med Biol; 2017; 1026():315-330. PubMed ID: 29282691
[TBL] [Abstract][Full Text] [Related]
16. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
Picard E; Verschoor CP; Ma GW; Pawelec G
Front Immunol; 2020; 11():369. PubMed ID: 32210966
[TBL] [Abstract][Full Text] [Related]
17. The perfect personalized cancer therapy: cancer vaccines against neoantigens.
Aurisicchio L; Pallocca M; Ciliberto G; Palombo F
J Exp Clin Cancer Res; 2018 Apr; 37(1):86. PubMed ID: 29678194
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations.
Remon J; Passiglia F; Ahn MJ; Barlesi F; Forde PM; Garon EB; Gettinger S; Goldberg SB; Herbst RS; Horn L; Kubota K; Lu S; Mezquita L; Paz-Ares L; Popat S; Schalper KA; Skoulidis F; Reck M; Adjei AA; Scagliotti GV
J Thorac Oncol; 2020 Jun; 15(6):914-947. PubMed ID: 32179179
[TBL] [Abstract][Full Text] [Related]
19. Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer.
Bendjama K; Quemeneur E
Hum Vaccin Immunother; 2017 Sep; 13(9):1997-2003. PubMed ID: 28846477
[TBL] [Abstract][Full Text] [Related]
20. Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments.
Niemi JVL; Sokolov AV; Schiƶth HB
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]